SLAS Technology

Nomad Biosensors: A New Multiplexed Technology for the Screening of GPCR Ligands

Nomad Technology (Innoprot [Innovative Technologies in Biological Systems], Derio, Spain), a novel tool for multiplexing high-throughput cell-based G protein-coupled receptor (GPCR) assays, is described in this work. This new technology comprises a family of fluorescent biosensors called Nomad Biosensors that allow for the measurement of responses mediated by G proteins through their interactions with second-messenger…

PLOS Neglected Tropical Diseases

Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease

Chagas disease remains one of the most neglected diseases in the world despite being the most important parasitic disease in Latin America. The characteristic chronic manifestation of chagasic cardiomyopathy is the region’s leading cause of heart-related illness, causing significant mortality and morbidity. Due to the limited available therapeutic options, new drugs are urgently needed to…

photo-BioEurope

Meet us at the International Partnering Conference Bio-Europe

Innoprot will be attending the 23rd Annual International Partnering Conference BIO-EUROPE to be held in Berlin, Germany, 6-8 November 2017.  Jorge Gamiz – Business Development Director, will be available to meet during the Conference to discuss the company’s capabilities, strategic partnership and collaboration interests. According to BIO-Europe, last year’s Conference hosted 20,833 on-to-one meeting among…

PHOTO-PATENT

EPO patent granted

Innoprot is pleased to announce the granting of EPO (European Patent Office) patent on its core GPCR Screening technology on June 7th 2017. Innoprot received notice of the granting of EPO (European Patent Office) patent on its core technology for GPCR Screening. This broadens proprietary protection of the company’s core technology to all European countries.…